Abstract
In recent years, long noncoding RNAs (lncRNAs) have been shown to have critical roles in a broad range of cell biological processes. However, the activities of lncRNAs during ischemic stroke remain largely unknown. In this study, we carried out a genome-wide lncRNA microarray analysis in rat brains with ischemia/reperfusion (I/R) injury. The results revealed the differential expression of a subset of lncRNAs. Through the construction of lncRNA-mRNA co-expression networks, we identified lncRNA-N1LR as a novel I/R-induced lncRNA. The functions of lncRNA-N1LR were assessed by silencing and overexpressing this lncRNA in vitro and in vivo. We found that lncRNA-N1LR enhanced cell cycle progression and cell proliferation, and inhibited apoptosis in N2a cells subjected to in vitro ischemia (oxygen-glucose deprivation/reoxygenation, OGD/R). Furthermore, we showed that lncRNA-N1LR reduced neuronal apoptosis and neural cell loss in I/R-induced mouse brains. Mechanistically, we discovered that lncRNA-N1LR promoted neuroprotection probably through the inhibition of p53 phosphorylation on serine 15 in a manner that was independent of its location-associated gene Nck1. In summary, our results indicated that lncRNA-N1LR promoted neuroprotection against ischemic stroke probably by inactivating p53. Thus, we propose that lncRNA-N1LR may serve as a potential target for therapeutic intervention following ischemic brain injury.
Similar content being viewed by others
Change history
04 January 2017
An erratum to this article has been published.
References
Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S et al (2016) Heart disease and stroke statistics-2016 update: a report from the American heart association. Circulation 133(4):e38–e360. doi:10.1161/cir.0000000000000350
Mehta SL, Manhas N, Raghubir R (2007) Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Rev 54(1):34–66. doi:10.1016/j.brainresrev.2006.11.003
Sleutels F, Zwart R, Barlow DP (2002) The non-coding Air RNA is required for silencing autosomal imprinted genes. Nature 415(6873):810–813. doi:10.1038/415810a
Martianov I, Ramadass A, Serra Barros A, Chow N, Akoulitchev A (2007) Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript. Nature 445(7128):666–670. doi:10.1038/nature05519
Wu Z, Liu X, Liu L, Deng H, Zhang J, Xu Q, Cen B, Ji A (2014) Regulation of lncRNA expression. Cell Mol Biol Lett 19(4):561–575. doi:10.2478/s11658-014-0212-6
Yang F, Zhang L, Huo XS, Yuan JH, Xu D, Yuan SX, Zhu N, Zhou WP et al (2011) Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology 54(5):1679–1689. doi:10.1002/hep.24563
Wan G, Hu X, Liu Y, Han C, Sood AK, Calin GA, Zhang X, Lu X (2013) A novel non-coding RNA lncRNA-JADE connects DNA damage signalling to histone H4 acetylation. EMBO J 32(21):2833–2847. doi:10.1038/emboj.2013.221
Wu P, Zuo X, Deng H, Liu X, Liu L, Ji A (2013) Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases. Brain Res Bull 97:69–80. doi:10.1016/j.brainresbull.2013.06.001
Dharap A, Nakka VP, Vemuganti R (2012) Effect of focal ischemia on long noncoding RNAs. Stroke; A Journal of Cerebral Circulation 43(10):2800–2802. doi:10.1161/STROKEAHA.112.669465
Begum G, Yuan H, Kahle KT, Li L, Wang S, Shi Y, Shmukler BE, Yang SS et al (2015) Inhibition of WNK3 kinase signaling reduces brain damage and accelerates neurological recovery after stroke. Stroke; A Journal of Cerebral Circulation 46(7):1956–1965. doi:10.1161/strokeaha.115.008939
Chi W, Meng F, Li Y, Wang Q, Wang G, Han S, Wang P, Li J (2014) Downregulation of miRNA-134 protects neural cells against ischemic injury in N2A cells and mouse brain with ischemic stroke by targeting HSPA12B. Neuroscience 277:111–122. doi:10.1016/j.neuroscience.2014.06.062
Tatlisumak T, Takano K, Carano RA, Fisher M (1996) Effect of basic fibroblast growth factor on experimental focal ischemia studied by diffusion-weighted and perfusion imaging. Stroke; A Journal of Cerebral Circulation 27(12):2292–2297 discussion 2298
Ashwal S, Tone B, Tian HR, Cole DJ, Liwnicz BH, Pearce WJ (1999) Core and penumbral nitric oxide synthase activity during cerebral ischemia and reperfusion in the rat pup. Pediatr Res 46(4):390–400. doi:10.1203/00006450-199910000-00006
Chen J, Deng F, Singh SV, Wang QJ (2008) Protein kinase D3 (PKD3) contributes to prostate cancer cell growth and survival through a PKCepsilon/PKD3 pathway downstream of Akt and ERK 1/2. Cancer Res 68(10):3844–3853. doi:10.1158/0008-5472.can-07-5156
Nayak RR, Kearns M, Spielman RS, Cheung VG (2009) Coexpression network based on natural variation in human gene expression reveals gene interactions and functions. Genome Res 19(11):1953–1962. doi:10.1101/gr.097600.109
DiFiglia M, Sena-Esteves M, Chase K, Sapp E, Pfister E, Sass M, Yoder J, Reeves P et al (2007) Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits. Proc Natl Acad Sci U S A 104(43):17204–17209. doi:10.1073/pnas.0708285104
Dubrac A, Genet G, Ola R, Zhang F, Pibouin-Fragner L, Han J, Zhang J, Thomas JL et al (2016) Targeting NCK-mediated endothelial cell front-rear polarity inhibits neovascularization. Circulation 133(4):409–421. doi:10.1161/circulationaha.115.017537
Chen J, Leskov IL, Yurdagul A Jr, Thiel B, Kevil CG, Stokes KY, Orr AW (2015) Recruitment of the adaptor protein Nck to PECAM-1 couples oxidative stress to canonical NF-kappaB signaling and inflammation. Sci Signal 8(365):ra20. doi:10.1126/scisignal.2005648
Leker RR, Aharonowiz M, Greig NH, Ovadia H (2004) The role of p53-induced apoptosis in cerebral ischemia: effects of the p53 inhibitor pifithrin alpha. Exp Neurol 187(2):478–486. doi:10.1016/j.expneurol.2004.01.030
Maeda K, Hata R, Gillardon F, Hossmann KA (2001) Aggravation of brain injury after transient focal ischemia in p53-deficient mice. Brain Res Mol Brain Res 88(1–2):54–61
Culmsee C, Zhu X, Yu QS, Chan SL, Camandola S, Guo Z, Greig NH, Mattson MP (2001) A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide. J Neurochem 77(1):220–228
Chen H, Yoshioka H, Kim GS, Jung JE, Okami N, Sakata H, Maier CM, Narasimhan P et al (2011) Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection. Antioxid Redox Signal 14(8):1505–1517. doi:10.1089/ars.2010.3576
Crumrine RC, Thomas AL, Morgan PF (1994) Attenuation of p53 expression protects against focal ischemic damage in transgenic mice. J Cereb Blood Flow Metab 14(6):887–891. doi:10.1038/jcbfm.1994.119
Yin KJ, Deng Z, Hamblin M, Xiang Y, Huang H, Zhang J, Jiang X, Wang Y et al (2010) Peroxisome proliferator-activated receptor delta regulation of miR-15a in ischemia-induced cerebral vascular endothelial injury. J Neurosci 30(18):6398–6408. doi:10.1523/jneurosci.0780-10.2010
Yin KJ, Deng Z, Huang H, Hamblin M, Xie C, Zhang J, Chen YE (2010) miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiol Dis 38(1):17–26. doi:10.1016/j.nbd.2009.12.021
Harraz MM, Eacker SM, Wang X, Dawson TM, Dawson VL (2012) MicroRNA-223 is neuroprotective by targeting glutamate receptors. Proc Natl Acad Sci U S A 109(46):18962–18967. doi:10.1073/pnas.1121288109
Martens JA, Laprade L, Winston F (2004) Intergenic transcription is required to repress the Saccharomyces cerevisiae SER3 gene. Nature 429(6991):571–574. doi:10.1038/nature02538
Doyle KP, Simon RP, Stenzel-Poore MP (2008) Mechanisms of ischemic brain damage. Neuropharmacology 55(3):310–318. doi:10.1016/j.neuropharm.2008.01.005
Errington TM, Macara IG (2013) Depletion of the adaptor protein NCK increases UV-induced p53 phosphorylation and promotes apoptosis. PLoS One 8(9):e76204. doi:10.1371/journal.pone.0076204
Banasiak KJ, Haddad GG (1998) Hypoxia-induced apoptosis: effect of hypoxic severity and role of p53 in neuronal cell death. Brain Res 797(2):295–304
Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C et al (1998) Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281(5383):1674–1677
Acknowledgments
We thank the Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation for flow cytometry support. This work was supported by the National Nature Science Foundation of China grant NSFC81370449.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Zhuomin Wu and Ping Wu contributed equally to this work.
An erratum to this article is available at https://doi.org/10.1007/s12035-016-0354-9.
Electronic supplementary material
Table S1
Sequences of primers and siRNA used in this study. (DOCX 19 kb)
Table S2
Differentially expressed lncRNAs identified in ischemic penumbra tissue. (PDF 490 kb)
Table S3
Differentially expressed mRNAs identified in ischemic penumbra tissue. (PDF 787 kb)
Table S4
The functions of mRNAs up-regulated over 100 fold-changes in ischemic penumbra. (PDF 221 kb)
Table S5
Functions of genes connected to lncRNA-N1LR in sub-network. (PDF 48 kb)
Rights and permissions
About this article
Cite this article
Wu, Z., Wu, P., Zuo, X. et al. LncRNA-N1LR Enhances Neuroprotection Against Ischemic Stroke Probably by Inhibiting p53 Phosphorylation. Mol Neurobiol 54, 7670–7685 (2017). https://doi.org/10.1007/s12035-016-0246-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-016-0246-z